Skin conditions (dermatitis, eczema, psoriasis) decisions — 2022

The Veteran's claims for service connection and a rating for his left ankle disorder, migraine headaches, skin disorders other than dermatophytosis, and tension headaches are being remanded due to the need for additional medical opinions. The Veteran also has new and material evidence presented to reopen his claim of service connection for a left ankle disorder.

The Veteran's service-connected disabilities result in the loss of use of both lower extremities, affecting balance and propulsion. The Board finds that he is eligible for specially adapted housing but not for special home adaptation grants due to his existing eligibility for SAH.

The Board has remanded the claims for service connection for sinusitis, pseudofolliculitis barbae, back condition, right knee condition, left knee condition, rhinitis, and bilateral foot pain/condition due to duty to assist errors.

The Board has decided to remand the claim of entitlement to a compensable disability evaluation for acne due to insufficient development and consideration.

The Board has determined that there was not substantial compliance with the previous remand directives and another remand is necessary due to incomplete etiological opinions regarding service connection for dermatitis.

Your appeal for an increase in the rating for your cystic acne has been dismissed as you have withdrawn it.

The Board denied the Veteran's claims of service connection for left great toe, left ankle, right ankle, and right shoulder disabilities. The evidence did not support a finding that these conditions were incurred or aggravated by military service.

The Veteran's tinea versicolor was previously rated at 30 percent, and the reduction to noncompensable was found to be improper. The current rating remains at 30 percent.

The Veteran's CAD was granted a 100% rating effective April 16, 2018. Service connection for tinea and asthma were also established, but BPH was denied.,TDIU was granted from February 1, 2012.

The Board has remanded the case due to a lack of VA examination, and the Veteran was not properly notified of the scheduled examination. The matter is now pending for further evaluation.

The Board has remanded the claims for gastrointestinal, skin, and sinus conditions due to additional development being necessary.

The Board denied the Veteran's claim for service connection for skin disorder (claimed as skin itch) due to a lack of evidence linking his current conditions to military service, specifically exposure to toxins at Camp Lejeune. The Board found that there is no nexus between the Veteran's present skin disorders and military service.

The Board has granted service connection for lumbago, but the claim for PFB remains pending and is remanded.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on the need for aid and attendance/housebound due to his service-connected disabilities not meeting the criteria for SMC at the housebound rate.

The Veteran's service-connected disabilities, including psoriasis, cervical spine disability, low back disability, radiculopathy of the bilateral upper extremities, left shoulder disability, residuals of a left fibula scar, and other conditions, have rendered him unemployable since August 23, 2013. The Board has granted TDIU benefits from that date.

The Veteran's acquired psychiatric disability, including PTSD and Bipolar Disorder, is now granted as service-connected.,His bilateral hearing loss claim remains pending due to the need for a VA examination.

The Board has remanded the case due to inadequate development and further examination is required.

The Board has remanded the case due to a lack of proper notification for a VA examination, and the Veteran should be scheduled for a new one.

The Veteran's claim for an initial compensable rating for bilateral tinea pedis/tinea unguium and service connection for an acquired psychiatric disorder is being remanded due to insufficient evidence in the record.

The Veteran's service-connected nummular dermatitis/eczema is granted a 10 percent rating from January 7, 2015 to February 6, 2017.